300+ investors in your industry, stage, and region Get
Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Oil and Gas
Social Impact
Retail
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Fitness
Organic Food
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Sustainability
Hardware
Biotech
Impact
Proptech
Transportation
Enterprise
Community
Media (Entertainment)
Theatre
Medical
Recruiting
Web3
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Oman
Burkina Faso
Poland
Puerto Rico
Cameroon
Guernsey
Andorra
Colombia
Sudan
China
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Moldova
Paraguay
Seychelles
Botswana
Japan
Ireland
Canada
United Kingdom
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Germany
India
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Argentina
Bangladesh
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Paul Tu, Venture Partner at Oxford Bioscience Partners

Paul Tu

Venture Partner @ Oxford Bioscience Partners

Paul Tu is a Series B investor at Oxford Bioscience Partners focused on Database and Security. Paul Tu has over 20 years of operational, entrepreneurial and investment experience. Paul is currently Managing Partner of Blue Ocean Equity Partners and leads the firm's acquisition activities. He is also a Venture Partner of Oxford Bioscience Partners. Most recently, Paul co-founded BGI Americas Corporation and brought BGI, a Chinesegenomics sequencing service provider, into the US market. As President of BGI Americas, Paul built a full staff and achieved positive returns within the first year of operations, and collaborated with leading pharmaceutical companies, including Merck, Pfizer, Novartis and Eli Lilly, etc..Prior to BGI Americas, Paul was a Principal at MassVentures, a Boston-based venture capital firm. Over his 10 years at MassVentures, Paul was involved in all aspects of investing and managing investments in privately held companies, including serving on their boards of directors and working closely with their executives to develop strategies, recruit senior management and secure follow-on financing. Paul's previous investments included uTest, the world's largest marketplace for software testing services and winner of the "Most Innovative Company of the Year" by American Business Awards in 2011; Inceptor Inc., a search engine marketing software company acquired by SuperMedia (NASDAQ: SPMD); and Profile Systems, a supply chain management software and service provider acquired by Comergent Technologies Inc. and subsequently acquired by Sterling Commerce, a subsidiary of AT&T Inc. (NYSE: T). Before MassVentures, Paul was Vice President at Eastern Bank Commercial Lending Group and Assistant Vice President at Bank of America (formerly Fleet Bank/Shawmut Bank) Business Banking Group. Paul holds an MBA from MIT Sloan School of Management and a B.S. from Boston University.

Total investments:
1
Last investment:
Lead investor:
0%

Last updated:

Industries Paul Tu invests in

DatabaseSecuritySoftwareIT ManagementPrivate Cloud

Stages Paul Tu invests in

Series B

Countries Paul Tu invests in

United States

Investment Focus

Industry

  • Database 1 (100%)
  • Security 1 (100%)
  • Software 1 (100%)
  • IT Management 1 (100%)
  • Private Cloud 1 (100%)
See all 7 industries →

Investments

CompanyDescriptionRoundLinks
Ntirety Ntirety
Managing security and compliance is a strategic, economic imperative that directly impacts business outcomes. Ntirety is the only company that embeds compliant security throughout your IT and company culture. Protect the entirety of your enterprise through a comprehensive compliant security solution from a single relationship. With over 20 years ofexperience and deep security expertise, our three 24x7x365 US-based security operations centers (SOCs) simplify your risk management program with a comprehensive protection, recovery and assurance suite of services. Our approach helps you build resilient, adaptive operations throughout all your organization. Discover the award-winning Ntirety Compliant Security Solution that’s tested, proven, and trusted globally. Learn more at ntirety.com. Series B / Mar 26, 2008
Oxford Bioscience Partners

About Oxford Bioscience Partners

VC Fund · Boston, United States

Oxford Bioscience Partners (OBP), established in 1992, is a venture capital firm that provides equity financing and management assistance to emerging, entrepreneurial-driven companies within the life sciences and healthcare sectors. While willing to consider an investment in a company at almost any stage, OBP primarily works with early-stagesituations. With approximately $1B of committed capital under management, OBP has invested in over 140 life science companies worldwide.

Oxford Bioscience Partners Contacts

NameEmailPhoneSocials
Alan G. Walton
Alan G. Walton Senior General Partner
Alan Watson
Alan Watson Executive-in-Residence
Julia Dan
Julia Dan Venture Partner
Manuel A. Navia
Manuel A. Navia Executive-in-Residence
Paul Tu
Paul Tu Venture Partner

Sign up to unlock verified contacts

Unlock Contacts
Open Oxford Bioscience Partners full profile

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Oil and Gas
Social Impact
Retail
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Fitness
Organic Food
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Sustainability
Hardware
Biotech
Impact
Proptech
Transportation
Enterprise
Community
Media (Entertainment)
Theatre
Medical
Recruiting
Web3
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Oman
Burkina Faso
Poland
Puerto Rico
Cameroon
Guernsey
Andorra
Colombia
Sudan
China
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Moldova
Paraguay
Seychelles
Botswana
Japan
Ireland
Canada
United Kingdom
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Germany
India
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Argentina
Bangladesh
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Paul Tu invest in?

Paul Tu invests primarily in Database, Security and Software startups, most often at Series B stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

When did Paul Tu last invest?

The most recent investment recorded for Paul Tu closed in Mar 2008. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Paul Tu Paul Tu Find email